Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Prosthetic-devices-including-elastin-or-elastin-based-materials

 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
What is claimed is: 1. A method for the treatment of a tumor in a mammal, comprising the steps of (...


 Methods for diagnosing early Lyme disease
This invention is based upon the discovery that sera from patients with early Lyme disease contain ...


 Tango 243 polypeptides and uses thereof
The present invention is based, at least in part, on the discovery of cDNA molecules which encode ...


 Dermatophagoides proteins and fragments thereof
What is claimed is: 1. An isolated protein comprising an amino acid sequence selected from the ...


 Tuberculin active proteins and peptides from the cells of tubercle bacilli
What is claimed is: 1. A tuberculin active simple protein from Mycobacterium tuberculosis strain A...


 Therapy for injured muscles
We claim: 1. A method for treating an injured muscle, the method comprising the step of local ...


 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1. PRO1560 A cDNA clone (DNA19902-1669) has been identified that encodes a novel polypeptide ...


 HIV-specific cytotoxic T-cell responses
OF INVENTION The inventors have found that two nanomer peptides, designated CLP-177 (SEQ ID NO:2) ...


 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions
OF PREFERRED EMBODIMENTS The present invention contemplates a method of immunomodulatory therapy ...


 Susceptibility mutation for breast and ovarian cancer
OF THE PREFERRED EMBODIMENTS The present invention is based on the discovery of a two base pair ...


 Prosthetic devices including elastin or elastin-based materials

Details
Inventors: Gregory, Kenton W.;
Assignee: Kenton W. Gregory & Sisters of Providence (Portland, OR)
Primary Examiner: Isabella; David J.
Assistant Examiner: Koh; Choon P.
Attorney, Agent or Firm: Marger Johnson & McCollom, P.C.

The invention is directed to a prosthetic device comprising a support member comprising a stent, a conduit or a scaffold; and a layer of elastin or elastin-based material located on said support member. Preferably, the layer of said elastin or elastin-based biomaterial completely surrounds said support member. The support member can be formed of a metal or a synthetic material such as a polymeric material.

DETAILED DESCRIPTION It is a specific object of the invention to provide an elastin-based prosthetic device suitable for use as a stent, for example, a vascular stent.
The present invention relates to a method of repairing, replacing or supporting a section of a body tissue.
The method comprises positioning an elastin or elastin based biomaterial at the site of the section and bonding the biomaterial to the site or to the tissue surrounding the site.
The bonding is effected by contacting the biomaterial and the site, or tissue surrounding the site, at the point at which said bonding is to be effected, with an energy absorbing agent.
The agent is then exposed to an amount of energy absorbable by the agent sufficient to bond the biomaterial to the site or to the tissue surrounding the site.
More specifically, a tissue-fusible elastin or elastin-based biomaterial can be produced using the process of the present invention which comprises a layer of elastin or elastin-based biomaterial and a tissue substrate each having first and second outer surfaces; and an energy absorbing material applied to at least one of the outer surfaces, the energy absorbing material penetrates into the biomaterial.
The energy absorbing material is energy absorptive within a predetermined range of light wavelengths.
The energy absorbing material is chosen so that when it is irradiated with light energy in the predetermined wavelength range, the intensity of that light will be sufficient to fuse together one of the first and second outer surfaces of the elastin or elastin-based biomaterial and the tissue substrate.
Preferably, the first and second outer surfaces of the elastin or elastin-based biomaterial are major surfaces.
Typically, the energy absorbing material is indirectly irradiated by directing the light energy first through the elastin or elastin-based biomaterial or tissue substrate and then to the energy absorbing material.
In a preferred process of this invention, the energy absorbing material comprises a biocompatible chromophore, more preferably an energy absorbing dye



Related patents
  Peptides containing N-substituted L-amino acids for preventing .beta.-strand association
The invention claimed is: 1. A peptide comprising a peptide, wherein: (a) said peptide comprises a .beta.-strand-forming section, said section consisting of four to ...
  Lectins and antiretroviral drugs containing the lectins as active ingredient
OF THE INVENTION The lectins of the present invention are obtained from the plants of the class Dicotyledoneae and have a function for inhibiting the reverse ...
  Activated dendritic cells and methods for their activation
The present invention pertains to a method of activating dendritic cells to enhance antigen presenting capacity. The activated, antigen-presenting dendritic cells of the ...
  Methods and compositions for obtaining mature dendritic cells
OF THE INVENTION This invention relates to methods and compositions useful for promoting the maturation of immature dendritic cells to a mature and stable phenotype as ...
  Nucleic acid encoding a lectin-derived progenitor cell preservation factor
It has now been discovered that these and other objectives can be achieved by the present invention, which provides an isolated nucleic acid comprising a nucleotide ...
  Ligand for vascular endothelial growth factor receptor
We claim: 1. A compound comprising amino acid sequence Glu-Ile-Glu-Trp-Tyr-Ser-Trp-Val-Thr-His-Gly-Met-Tyr (SEQ ID NO:29). 2. A pharmaceutical composition comprising ...
  Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
What is claimed is: 1. An immunologically active Borrelia burgdorferi protein free of other proteins isolated from Borrelia burgdorferi, which protein comprises SEQ ID NO...
  Immunoliposomes that optimize internalization into target cells
The present invention provides novel immunoliposomes optimized for delivering therapeutic agents to the cytoplasm of a target cell. These immunoliposomes exhibit ...
  Virus-like particles for the induction of autoantibodies
The inventors have discovered compositions and methods of increasing the titers of antibodies to tolerogens (e.g., self antigens and foreign antigens) over those titers ...
  Ferritin analogs
Despite the fact that ferritin is extremely selective in accumulating, storing and dispensing iron in living things, I have discovered that the forgoing objectives can ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved